Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in Western countries; it affects primarily older persons, with a median age at diagnosis of 72 years. Chlorambucil has been a standard first-line therapy in CLL, especially for older patients or those with coexisting…

from #Medicine via ola Kala on Inoreader http://ift.tt/1LXnLNe
via IFTTT